FARMINGDALE, N.Y.—-Misonix, Inc. , a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, announced today that it has extended its agreement with the Mentor Corporation for domestic sales of its ultrasound assisted liposuction product, the LySonix® 3000.
More: continued here
